U.S. Markets open in 1 hr 33 mins

Medidata to Present at Upcoming Investor Conferences


Medidata (MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that the company will present at the following upcoming investor conferences.

  • Rouven Bergmann, chief financial officer, will present at the JMP Securities Technology Conference on Monday, February 27, 2017, at 11:30 a.m. PT (2:30 p.m. ET) in San Francisco.
  • Tarek Sherif, chief executive officer, and Rouven Bergmann, chief financial officer, will present at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday, March 1, 2017, at 11:45 a.m. PT (2:45 p.m. ET) in San Francisco.

A live audio webcast will be available on the “Investor” section of Medidata’s website at http://investor.mdsol.com. Please visit the website at least 15 minutes prior to the event to register, download and install any necessary audio or video software to access the presentation. For those unable to participate in the live webcast, a replay will be archived on the “Investor” section of Medidata’s website at http://investor.mdsol.com for a limited period of time following the conference.

About Medidata

Medidata is reinventing global drug development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including nearly 850 global pharmaceutical companies, innovative biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.

The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 17 of the world's top 25 global pharmaceutical companies, from study design and planning through execution, management and reporting.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170222006538/en/